| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |